Follow
Diede van Ens
Diede van Ens
Unknown affiliation
Verified email at radboudumc.nl
Title
Cited by
Cited by
Year
Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses
J van Eck van der Sluijs, D van Ens, S Thordardottir, D Vodegel, ...
Cancer Immunology, Immunotherapy 70 (11), 3167-3181, 2021
142021
PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity
D van Ens, CM Mousset, TJA Hutten, AB van der Waart, D Campillo-Davo, ...
Bone Marrow Transplantation 55 (12), 2308-2318, 2020
142020
Actomyosin contractility requirements and reciprocal cell–tissue mechanics for cancer cell invasion through collagen-based channels
L Beunk, GJ Bakker, D van Ens, J Bugter, F Gal, M Svoren, P Friedl, ...
The European Physical Journal E 45 (5), 48, 2022
132022
Human CD34+-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8+ T cell and NK cell responses in …
J van Eck van der Sluijs, D van Ens, J Brummelman, D Heister, A Sareen, ...
Cellular and Molecular Life Sciences 80 (10), 298, 2023
2023
Quorum sensing dictates IFN-I response dynamics in human plasmacytoid dendritic cells
LC Van Eyndhoven, CC Vreezen, BM Tiemeijer, D van Ens, W Hobo, ...
Decoding type I interferon response dynamics using microfluidics and …, 2023
2023
HIGH-DIMENSIONAL PROFILING OF T AND NK CELL FREQUENCIES AND UNSUPERVISED CLUSTERING ANALYSES TO IDENTIFY IMMUNE (DYS) FUNCTIONAL PHENOTYPES IN MDS PATIENTS
D Van Ens, J Brummelman, V der Sluijs, J Van Eck, R Woestenenk, ...
LEUKEMIA RESEARCH 108, S36-S36, 2021
2021
Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation: HIGH-DIMENSIONAL PROFILING OF T AND NK CELL FREQUENCIES AND UNSUPERVISED CLUSTERING ANALYSES TO IDENTIFY …
D Van Ens, J Brummelman, JVE Van Der Sluijs, R Woestenenk, D Heister, ...
Leukemia Research 108, 106681.32, 2021
2021
PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity
CM Mousset, D van Ens, TJA Hutten, AB van der Waart, ...
Improvement of T cell Functionality in Cancer Immunotherapy–Time to AKT, 129, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–8